Comprehensive and long-term surveys of COVID-19 sequelae in Japan, an ambidirectional multicentre cohort study: study protocol
Kensuke Nakagawara(Keio University), Hidefumi Koh(Tachikawa Hospital), Sohei Nakayama(Beth Israel Deaconess Medical Center), Takashi Inoue(Japan Atomic Energy Agency), Tadashi Manabe(Keio University), Yoshitaka Oyamada(Keio University), Shuko Mashimo(Toyohashi Municipal Hospital), Sho Kanzaki(Keio University), Jun Yamagami(Keio University), Hirofumi Kamata(Keio University), Toshio Odani(National Hospital Organization Hokkaido Medical Center), Makoto Ishii(Tokyo Medical and Dental University), Keigo Kobayashi(Osaka Gakuin University), Takae Tanosaki(Keio University), Keita Masuzawa(Kitasato Institute Hospital), Shinnosuke Ikemura(Keio University), Keiko Ohgino(Keio University), Katsunori Masaki(Keio University), Eisuke Shimizu(Keio University), Soichiro Ueda(Social Insurance Saitama Chuo Hospital), Rie Baba(Saiseikai Utsunomiya hospital), Hideki Terai(Kitasato Institute Hospital), Hiroki Kabata(Keio University), Hajime Tabuchi(Keio University), Ichiro Nakachi(Saiseikai Utsunomiya hospital), Sei Harada(Keio University), Junko Kagyo(Kawasaki Municipal Hospital), Keitaro Fukuda, Shogyoku Bun(Keio University), Ho Namkoong(Keio University), Daisuke Ito(Mie University), Yoshiki Ishibashi(Keio University), Kyoko Shimamoto(Keio University), Hiromu Tanaka(Keio University), Hiroyuki Yasuda(Beth Israel Deaconess Medical Center), Yohei Funatsu(Keio University), Takashi Ishiguro(Saitama Prefecture), Satoshi Okamori(Keio University), Naoto Minematsu(Nagano Municipal Hospital), Shotaro Chubachi(Keio University), Ichiro Kawada(Keio University), Kengo Otsuka(Keio University), Naota Kuwahara(SHOWA Medical University), Ho Lee(Keio University), Toshiyuki Hirano(Sapporo Kosei General Hospital), Koichi Sayama(Beth Israel Deaconess Medical Center), Tetsuya Shiomi(keiyu Hospital), Takanori Fujita(Keio University), Naoki Miyao, Yusuke Suzuki(Keio University)
Cited by 19
Related Papers
Erlotinib plus bevacizumab versus erlotinib alone in patients with EGFR-positive advanced non-squamous non-small-cell lung cancer (NEJ026): interim analysis of an open-label, randomised, multicentre, phase 3 trial
|The Lancet Oncology|2019|642
Structural, Biochemical, and Clinical Characterization of Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Mutations in Lung Cancer
|Science Translational Medicine|2013|565
Mitochondrial dysfunction associated with increased oxidative stress and α-synuclein accumulation in PARK2 iPSC-derived neurons and postmortem brain tissue
|Molecular Brain|2012|392
Diagnosis and management of pemphigus: Recommendations of an international panel of experts
|Journal of the American Academy of Dermatology|2018|384